Introduction
Lung cancer is the leading cause of cancer death worldwide. Recently, the National Lung Screening Trial (NLST) demonstrated that, relative to chest x-ray, a 20% decrease in mortality was observed for high risk subjects screened with low dose chest CT [1] . Chest CT unavoidably images non-cardiovascular, non-pulmonary organs such as thyroid, adrenals, liver, kidneys and other structures in the upper abdomen. Moreover, when utilizing a low dose screening-chest CT protocol, the images are often noisy and incidental findings are suboptimally evaluated. It is important for radiologists involved in interpreting screening chest CTs to be aware of the prevalence and clinical implications of incidental findings. Detection of incidental findings is a double-edged sword. For the majority of patients, the potential benefits include reassurance when nothing ominous is found. Conversely, for a minority of patients, discovery of an unsuspected, but clinically significant process at an early stage may be of great value. The potential harms include undue anxiety, added time, morbidity and costs stemming from additional workup of findings that eventually prove to be of no clinical significance. Incidental cardiac, mediastinal and pulmonary findings in a lung cancer screening cohort have been reported previously [2, 3] . The objective of this study is to determine the prevalence and clinical significance of non-cardiovascular, non-pulmonary findings amongst participants enrolled in the CT arm of NLST at one institution.
represented benign appearance). If the thymic mass was larger than 3 cm or if necrosis or infiltration of mediastinal fat was seen, further workup was required [3] .
Stable well characterized simple cyst, adrenal adenomas, goiter without significant mass effect on trachea, small uncomplicated hiatal hernia or fat containing ventral hernia, small < 1cm thyroid hypodensities or mediastinal nodules and anatomic variants were considered clinically insignificant. Solid kidney mass, larger solid thymic, thyroid and adrenal masses, and mediastinal lymphadenopathy were considered clinically significant per current practice guidelines and findings not meeting these two criteria were included in variable clinical significance category. All of the scans were read by one radiologist who is fellowship-trained in both thoracic and body imaging.
Results
Of the eligible 1,572 subjects, 187 subjects revealed noncardiovascular, non-pulmonary findings for an overall prevalence of 11.9 % ( Table 1, Table 2 ). One hundred and thirty four (8.5%) exhibited findings of little or no clinical significance (category 1) for prevalence of 8.5 %. There was no change in size or attenuation of findings in any subject in category 1 on two subsequent annual screening CT scans. Incidental CT findings of variable clinical significance (category 2) were demonstrated in 44 out of 1572 subjects for prevalence rate of 2.8 %. One anterior mediastinal nodule increased in size and two cases of thyroid hypodensities were lost to follow-up in category 2. The findings in the remaining 41 did not change over two subsequent annual CT scans. The majority of incidental findings in category 1 and 2 were stable over a two year period ( Figure 1 , Figure 2 and Figure 3 ). Further evaluation of renal or hepatic cysts and thyroid nodules in category 1 and 2 by ultrasound was however recommended in one third of subjects. In addition, a wide variety of incidental congenital variants including aberrant right subclavian artery, duplicated inferior vena cava, or azygos continuation of inferior vena cava were not included in data analysis. Bone islands and synovial osteochondromatosis were also not included in data analysis. The prevalence rate of clinically significant findings (category 3) was 0.057% (9 out of 1572 subjects). Examples of malignancy in this study included lymphoma in two participants (Figure 4 ), renal cell cancer in three participants ( Figure  5 ) and thyroid cancer in one participant ( Figure 6 ) and thymomas in three participants. Further evaluation by CT or ultrasound was recommended for all the incidental findings in category 3.
Discussion
Incidental non-cardiovascular, non-pulmonary findings detected during screening chest CT were common and most were of little or no clinical significance. Renal cyst imaging categorization using Imaging Method and Analysis: The baseline and annual incident screening CT parameters met NLST specifications, and included a kVp of 120, effective mAs of 30, and reconstruction collimation and slice intervals of 2 mm. Participants underwent imaging with 4-, 16-or 64-detector row CT scanner (Definition 4-, 16 or sensation 64: Siemens Medical Solutions, Forchheim, Germany). Images were reconstructed with an edge-enhancing reconstruction algorithm for the lungs (viewed at window width of 1500, and window level of -700 HU) and a soft tissue reconstruction algorithm for the soft tissues (viewed at window width of 400, and window level of 40 HU). The original CT reports were reviewed for descriptors of noncardiovascular, non-pulmonary findings, including the size, location, and attenuation by MK and NS (both with > 5 years of experience). If the report was not clear, the corresponding images were reviewed by KG and DL (both NLST radiologists with > 15 years of reading screening CT experience). Follow-up recommendations for these incidental findings from the CT reports were also noted. Per NLST protocol, clinical follow-up was available by chart abstraction only for subjects who had positive screens or those who had clinically significant findings.
Using the current imaging criteria, a hepatic or renal simple cyst was diagnosed when a lesion had a uniformly low attenuation coefficient of 20 H units or less. An adrenal adenoma was diagnosed when there was a small, well-defined round or oval mass with homogeneous low attenuation of < 10 H units. The thyroid gland was assessed for single or multiple hypodense nodules. The nodule was assessed for size, location, density, the presence or absence of calcifications, margins and overall size of the gland [4] . The location of each mediastinal mass was classified according to the mediastinal compartment, superior or inferior, with the latter subclassified as anterior, middle or posterior, and also according to the likely organ involved on the basis of location of the mass. The length and width of the mass were measured and the diameter and average of the length and width was calculated. The CT numbers were obtained for each mass to determine whether it was cystic or solid or containing fat. Calcifications and necrosis of the mass as well as infiltration of the surrounding mediastinal fat were documented. All subsequent CT scans were reviewed to assess change in size (increased, no change, decreased). An attempt was made to get the pathology report if the mass was resected for pathologic diagnosis. Each thymic mass was evaluated for its shape: ovoid, bilobed or arrowhead; the latter two Bosniak criteria has been widely accepted [5] . For suspicious lesions a dedicated contrast enhanced renal CT or MR is recommended. In low risk population, incidentally discovered liver cysts demonstrating sharply defined margins and low-attenuation (20 HU) do not need further evaluation. We may have underestimated the prevalence of smaller cysts given noisy images; however, all the cysts categorized as simple or Bosniak one category were stable over three annual screening CT scans. Ultrasound was suggested in approximately 50% in our study for some of the simple cysts and thyroid nodules which were not well characterized at baseline CT due to noisy images likely resulting in anxiety and cost of care, however cost-effectiveness was not the focus of this paper.
One of the commonest incidental findings was an adrenal adenoma ( Table 2) . We used the widely accepted criteria to diagnose adrenal adenomas; attenuation coefficient of < 10 Hounsfield Units (HU) on unenhanced CT and lack of change for at least 1 year [6] . In another study incidentally detected adrenal masses with a CT attenuation of > 10 HU units were also found to be benign in patients with no known malignancy [7] . For indeterminate adrenal nodules further characterization by contrast enhanced CT shows absolute contrast washout of > 50% at 10 minutes or 60% at 15 minutes [6] . Chemical shift MRI with cancellation or signal dropout on opposedphased MR imaging is virtually diagnostic of an adenoma. In this study for adrenal nodules without confirmatory imaging, at least one year of stability on follow-up examination was used as imaging proof for benignity, in fact two year imaging follow-up was available for most of the incidental adrenal masses. It is possible that some unsuspected functioning adrenal masses were missed in our study because biochemical screening was not routinely performed. The incidence of unsuspected functioning adrenal masses is low, reportedly 1% or less [8] . Follow-up imaging recommendations regarding adrenal nodules that were used in this study and now formally proposed in a white paper have been widely accepted [9] . Adrenal nodule demonstrating HU of less than 10 requires no further work-up. Adrenal nodules demonstrating attenuation of more than 10 HU and measuring 1-4 cm can be followed for one year with either CT or MRI, and if they remain stable, no further workup is necessary. However, a dedicated adrenal CT or MRI protocol is recommended if an adrenal nodule measures greater than 4 cm [9, 10] .
Incidental abnormalities of the thyroid gland were also commonly encountered (Table 2 ). Varied rate of 2-67% incidental thyroid findings is reported on cross-sectional imaging [11] [12] [13] and 9% on sonography [14] . Since there are no established CT features which reliably distinguish benign from malignant thyroid lesions, several management strategies may be employed by the interpreting radiologist, ranging from further imaging by sonography in all cases or further follow-up only for nodules bigger than 1.5 cm [4] . Sonography was recommended only for larger nodules in our study and to the best of our knowledge there was no missed thyroid cancer. In a recent publication, a prevalence rate of 11.3% was reported for malignant or potentially malignant lesions amongst incidental thyroid abnormalities detected on CT [15] similar to what was found in this study (1 of 9 cases). An appropriate management algorithm requires knowledge of the imaging and demographic features that may predict malignancy. Family history, prior radiation therapy, history of multiple endocrine neoplasm 2, history of thyroid cancer, young age and male gender have all been implicated as predisposing factors to thyroid cancer [16] . Thyroid nodules that are less than 1 cm in size without predisposing factors can just be mentioned in the report without the need for further workup. Nodules associated with cervical adenopathy and/or with fluoro-deoxyglucose (FDG) uptake on PET CT are considered suspicious, requiring ultrasound work up, with or without FNA biopsy [11] .
Underestimation of incidental findings in our study is possible. However, the prevalence and clinical importance of incidental findings was not much different than reported on recent CT colonography studies [17] [18] [19] . The majority of patients (86.6%) were either negative for extracolonic findings or had unimportant extracolonic findings, likely unimportant but indeterminate extracolonic findings where further workup might be indicated were found in 11.3% of patients, whereas 2.1% had likely important extracolonic findings in one study [19] .
In another recent study evaluating prospective CT screening for lung cancer in HIV-positive smokers (median age 48 years Vs 65 years in our study), extrathoracic incidental findings were noted in 40% of patients with the majority being renal and hepatic abnormalities, similar to this study. Participants in this study had a baseline screening CT and up to 4 scans annually compared to only 2 scans in NLST. However, in contrast to our study, no extrapulmonary malignancy was identified; this difference may be due to the younger age of subjects in their study [20] . Other limitation of this study is the lack of longer follow-up as some slow-growing malignancies may have been missed.
As screening chest CT becomes a standard of practice, radiologists not only need to be aware of the prevalence and significance of incidental findings on screening chest CTs, but also need to report their findings in a concise, standardized manner to help triage and guide follow up appropriately. Similar to current guidelines of reporting findings on CT colonoscopy [18, 19] , we propose categorizing the non-cardiopulmonary, non-pulmonary findings into an easily implementable system (Table 2 ).
Summary
Incidental non-cardiovascular, non-pulmonary findings detected during screening chest CT are common and most are of little or no clinical significance. In the ever evolving practice of medicine, now focused on quality and costs of care, radiologists must be cognizant of the recommendations made regarding incidental findings on screening chest CT examinations. Guidelines reviewed herein pertain to several commonly encountered incidental findings including adrenal and thyroid nodules. However, many other findings do not have established guidelines and appropriate recommendations remains a work-in-progress. Variability in reporting and follow-up of incidental findings needs to be standardized to avoid patient's anxiety, medical cost inflation and to ensure quality care.
